FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells

Oncogene
M R JohnsonA Mansukhani

Abstract

Normal breast tissue as well as most breast tumors are dependent on estrogen for growth. Breast tumors often progress to a hormone-independent state which is associated with poor prognosis. It has been proposed that activation of growth factor signaling pathways in the tumor cells may free them from hormonal control. Certain growth factors can mimic estrogen responses by activating the estrogen receptor via its phosphorylation by mitogen-activated protein (MAP) kinase. In this report, however, we show that fibroblast growth factor (FGF), despite activating MAP kinase, is growth-inhibitory for estrogen-dependent MCF-7 breast cancer cells. MCF-7 cells treated with FGFs exhibit slower growth than controls in both the presence and absence of estrogen, with a concomitant increase in the number of cells in G0/G1. Expression of a constitutively activated FGF receptor in these cells further decreases their growth rate, which is no longer influenced by FGF treatment. Activation of the FGF signaling pathway also reduces the induction of an estrogen-responsive CAT reporter plasmid by estrogen, an effect which appears to be independent of serine 118 in the estrogen receptor, a MAP kinase target site. The inhibitory effects of FGF are proba...Continue Reading

Citations

Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·Y DobashiT Kameya
Feb 5, 2003·Biochemical Pharmacology·Martine GarnierJean-Charles Faye
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D LiuR C Coombes
Nov 30, 2011·The Journal of Experimental Medicine·Aya KobayashiKounosuke Watabe
Sep 3, 2002·American Journal of Respiratory Cell and Molecular Biology·Yuzo KodamaJanet L Martin
Jan 21, 2017·Kidney International·Maria FragiadakiAlbert C M Ong
Mar 18, 2020·The Journal of Experimental Medicine·Xiaoyan ZhanJianghong Man
Nov 19, 2003·The Journal of Biological Chemistry·Juan J Sironi, Toru Ouchi
Jun 15, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·E M ValveP L Härkönen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.